A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients

A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients

Abstract Background Currently, the clinical strategy for diagnosis of non-muscle invasive bladder cancer (NMIBC) such as cystoscopy and cytology are invasive and/or with limited accuracy. OncoUrine, a urinary assay for mutation and methylation biomarkers, have showed a high accuracy in the detection...

Full description

Bibliographic Details
Main Authors: Hai Huang, Ao Liu, Yiming Liang, Yaqun Xin, Jiacheng Liu, Yining Hao, Da Huang, Lu Chen, Wei Li, Guangliang Jiang, Yuhua Huang, Yaoting Xu, Jie Zhang, Tonghui Ma, Danfeng Xu, Yi Gao
Format: Article
Language:English
Published: BMC 2023-09-01
Series:BMC Medicine
Subjects:
Non-muscle invasive bladder cancer
Cystoscopy
Mutation
Methylation
Diagnosis
Recurrence surveillance
Online Access:https://doi.org/10.1186/s12916-023-03065-5

Internet

https://doi.org/10.1186/s12916-023-03065-5

Similar Items